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Ribosomes in lysates prepared from the mycelia of Aspergillus giganteus MDH 18894, which are actively secreting 
a-sarcin, do not contain the a-sank lesion. However, the addition of exogenous a-sarcin to these same lysates results 
in cleavage of the 26 S rRNA of the 60 S ribosomal subunit, characteristic of the cytotoxic action of a-sarcin. We conclude 
that A. gigunteus ribosomes are not inherently resistant o the action of a-sarcin but are protected in vivo by producing 
a-sarcin in an inactive form and/or by the efficient cotranslational secretion of the toxin. 
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1. INTRODUCTION 
The mold Aspergillus giganteus MDH 18894 
produces and secretes the toxin a-sarcin [1,2], 
which inhibits protein synthesis. The cytotoxic ac- 
tion of cy-sarcin results from the inactivation of the 
ribosomes [3,4] brought about by the enzymatic 
hydrolysis of a specific phosphodiester bond near 
the 3 ’ -terminus of the largest rRNA [5-71. The se- 
quence of the a-sarcin cleavage site appears to be 
universally conserved and has been found in the 
large rRNA of cytoplasmic and organellar 
ribosomes of eucaryotes, and in the ribosomes of 
procaryotes 171. All ribosomes thus far tested have 
been found to be sensitive to the hydrolytic action 
of cy-sarcin; i.e. Saccharomyces cerevisiae [5,6], 
wheat germ [5], rat liver [6,7], rabbit reticulocytes 
[4], and Escherichia coli [5,6]. These observations 
raise the question of how A. giganteus protects 
itself from the cytotoxic effects of mu-sarcin. Here, 
we have sought to determine if the ribosomes of A. 
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giganteus MDH 18894 are inherently resistant to 
a-sarcin. 
2. MATERIALS AND METHODS 
The lyophilized culture of A. gigunteus MDH 18894, which 
was used in the initial isolation of cu-sarcin [2], was a generous 
gift from T. Watson (Michigan Department of Health). A. 
gigunteus cultures were grown at 30°C for 48 h in the cu-sarcin 
inducing medium (medium A) recommended by Olson et al. [l]. 
S. cerevisiue SSL204 [fi] was a gift from D.M. Livingston 
(University of Minnesota) and was grown at 30°C in YM-1 
medium [9]. Aspergillus nidulans ATCC 10074 was purchased 
from the American Type Culture Collection and was grown 
under the conditions recommended by the supplier. Ricin A- 
chain was purchased from Calbiochem and cu-sarcin was a gift 
from I.G. Wool (University of Chicago). 
Ribosomal lysates were prepared by the method of Hofbauer 
et al. [lo] from washed mycelia or cells. The method of Endo 
and Wool [6] was employed to assay ribosome sensitivity and 
cr-sarcin activity in the culture filtrates. Lysates containing 
45 Fg ribosomes were treated with either cu-sarcin (100 ng), ricin 
A-chain (100 ng), or aspergillus culture filtrates (1.0~1) for 
30 min at 37°C in a total volume of 60 ~1. The reaction was ter- 
minated by the addition of 5 vols of 1% SDS in 50 mM Tris- 
HCl (pH 7.4). Total rRNA was phenol extracted, ethanol 
precipitated, and analyzed by electrophoresis on 6% 
polyacrylamide-7 M urea gels [l 11. The rRNA was visualized by 
silver staining [12]. For ricin A-chain treatment, the 
precipitated rRNA was incubated in 1 .O M aniline-acetate (pH 
4.5) for 10 min at 0°C to catalyze the hydrolysis of the rRNA 
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at the apurinic site created byricin [13]. Aniline was removed 
by ether extraction and the rRNA was ethanol precipitated prior 
to electrophoresis. 
3. RESULTS 
The characteristic rRNA lesion produced by LY- 
sarcin can be readily visualized by polyacrylamide 
gel electrophoresis of total rRNA (fig. 1). Since the 
location of the a-sarcin cleavage site in A. 
giganfeus rRNA is unknown, several control ex- 
periments were included to locate this site. The 
fragments produced by the treatment of S. 
cerevisiae lysates with cY-sarcin and ricin A-chain 
followed by aniline hydrolysis were used for com- 
parative purposes. In yeast ribosomes, the cu-sarcin 
cleavage site is near the 3 ‘-terminus of the 26 S 
rRNA and the resulting fragment (fig.lA, lane 4) 
is 367 bases in length [6]. Ricin A-chain removes a 
base one residue to the 5 ‘-side of the cu-sarcin 
cleavage site [13]. The rRNA fragment produced 
by aniline-catalyzed hydrolysis of the phospho- 
diester bond at the apurinic site created by ricin 
treatment (fig.lA, lane 3) is one residue longer 
than that produced by a-sarcin (Stirpe et al., sub- 
mitted and [13]). Since the ribosomes of aspergilli 
are similar to those of yeast with respect o the size 
of the large rRNA [14], it is likely that the 
fragments produced by a-sarcin and ricin followed 
by aniline hydrolysis would also be similar. A. 
nidulans ATCC 10074 does not produce cy-sarcin 
(not shown) and control experiments using lysates 
of this organism are also shown (fig.lC). The 
fragments produced by aniline hydrolysis of the 
rRNA from ricin-modified ribosomes (fig. lC, lane 
3) and by a-sarcin (fig.lC, lane 4) in A. nidulans 
ribosomes are indistinguishable from those of 
yeast rRNA. 
We have confirmed the production and secretion 
of a-sarcin by A. giganteus MDH 18894 [l] under 
the growth conditions we have employed in the 
preparation of the ribosomal lysates (not shown). 
This is important since not all isolates of A. 
giganteus produce cu-sarcin (Watson, T., personal 
communication). The rRNA of these ribosomes 
did not contain the characteristic a-sarcin lesion 
(fig.lB, lane 1). This demonstrates that the 
ribosomes have not been acted upon by cu-sarcin 
either in the cytoplasm of the intact cell or during 
the preparation of lysates. Treatment of these 
lysates with exogenous cu-sarcin, however, caused 
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Fig. 1. Gel electrophoretic analysis of ribosome sensitivity to CY- 
sarcin and ricin A-chain. Lysates were isolated from: (A) S. 
cerevisiue SSL204; (B) cu-sarcin-producing mycelia of A. 
giganteus MDH 18894; and (C) A. nidulans ATCC 10074. 
Lysates were treated as follows: (lanes) 1, control; 2, control 
followed by aniline treatment of the rRNA; 3, ricin A-chain 
followed by aniline treatment of the rRNA; 4, cu-sarcin. The 
arrow designates the position of the rRNA fragment produced 
by cY-sarcin. 
cleavage of the rRNA (fig.lB, lane 4) as 
demonstrated by the appearance of the 
characteristic rRNA fragment (shown by the ar- 
row). The fragment produced by cu-sarcin com- 
igrates .with the fragment produced by aniline 
hydrolysis of rRNA from A. giganteus ribosomes 
pretreated with ricin A-chain (fig.lB, lane 3). 
These observations demonstrate that the 
ribosomes of A. giganteus MDH 18894, which are 
actively producing cu-sarcin, do not contain the cy- 
sarcin lesion in vivo but are themselves inherently 
sensitive to the action of the toxin. 
4. DISCUSSION 
A great deal is known about the strategies 
employed by bacteria to protect themselves from 
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the cytotoxic effects of the ribosome-inhibiting an- 
tibiotics which they produce (review [15]). Some 
organisms defend themselves by modifying the 
ribosomal target of the antibiotic. A particularly 
relevant example of this strategy is provided by the 
thiostrepton-producing organism Streptomyces 
azureus. The binding to and inhibition of 
ribosomes by thiostrepton are completely 
prevented in S. azureus by the post-transcriptional 
methylation of specific bases within the 
thiostrepton-binding region of the 23 S rRNA. On 
the other hand, selection for thiostrepton 
resistance in nonproducing organisms has yielded 
mutants with alterations in the r-protein which in- 
teracts with the portion of rRNA to which 
thiostrepton binds [ 151. Thus, protection against 
the action of antibiotics which inhibit the ribosome 
by interacting with rRNA can be achieved by 
alterations in either rRNA or r-proteins. 
Much less is known about the strategies of self- 
defense employed by organisms which produce 
toxic proteins that catalytically inactivate the 
ribosome. The best studied example of such self- 
defense against a catalytic inhibitor is found in col- 
icin E3-producing bacteria. The cytotoxic effect of 
colicin E3, like a-sarcin, results from the specific 
cleavage of rRNA [16]. Ribosomes of the colicin- 
producing organism are inherently sensitive to the 
action of colicin E3 but are protected by an ‘im- 
munity protein’ which binds to and inactivates col- 
icin E3 within the cell [ 161. It is also possible that 
protection against toxic proteins may be achieved 
through their initial production as inactive 
zymogens which are activated only after secretion, 
as exemplified by the zymogens of the pancreatic 
proteases [17]. Alternatively, protection against 
the action of extracellular protein toxins may be 
achieved by efficient co-translational secretion 
[ 181. It is widely assumed that plant ribosomes are 
resistant o the action of the ribosome-inactivating 
proteins, such as ricin, which they produce [19]. 
However, the basis of this presumed resistance has 
not been defined and it has been suggested that 
resistance may not apply to all plants which pro- 
duce ribosome-inactivating proteins [20]. 
We have demonstrated that ribosomes isolated 
from cu-sarcin-producing cultures of A. giganteus 
do not contain the a-sarcin lesion but that these 
ribosomes are inherently sensitive to the toxin in 
vitro. We conclude that A. giganteus ribosomes 
390 
are protected from the action of the toxin in vivo 
either because the intracellular form of u-sarcin is 
inactive and/or because the protein is efficiently 
secreted. 
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